Reconstruction of Hand Soft Tissue Defects

Reliability and Versatility of Posterior Interosseous Artery Flap in Reconstructing Hand Soft Tissue Defects.

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05218252

Enrollment

Registered

2022-02-01

Start date

2022-01-06

Completion date

2022-12-31

Last updated

2022-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand Injuries

Keywords

Posterior interosseous artery flap, Hand soft tissue defects

Brief summary

Evaluation of distally based posterior interosseous artery flap in reconstructing hand soft tissue defects that may result from trauma, extensive burns, tumor resection or congenital deformities.

Interventions

PROCEDUREPosterior interosseous artery flap

The use of distally based posterior interosseous artery flap from the forearm in reconstructing mild to moderate hand soft tissue defects

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

3 Years to 60 Years

Healthy volunteers

Inclusion criteria

1. Patients with complex defects over the dorsal and palmar aspect of the wrist and the hand up to the proximal interphalangeal joint level, the whole thumb, and the first web space. 2. Small to moderate hand defects resulting from post-traumatic raw areas, post-traumatic deformities, postburn deformities and scar, post tumor resection, and congenital hand deformity. 3. Availability of a healthy donor site.

Exclusion criteria

1. Patients with a major uncontrollable medical illness. 2. Chronic heavy smokers. 3. Traumatic injury to the donor site. 4. Complex defects of the hand beyond the PIP joint level.

Design outcomes

Primary

Measure	Time frame	Description
Functional and aesthetic outcomes of posterior interosseous artery flap	5 months from the end of treatment	All patients will be evaluated with objective (functional) and subjective (aesthetic) criteria. Hand functionality will be evaluated using the disability of the arm, shoulder, and hand (DASH) score. The DASH score comprises 30 questions, and the score ranges from 30 points, for no limitation, to 150 points, for maximum limitation. The outcomes will be aesthetically reviewed with scar assessment measured as being good, fair, and poor. This assessment is subjective. Donor site problems are identiﬁed as cold intolerance, numbness, and pain. These will be evaluated as being either present in the patient or non-existent.

Countries

Egypt

Contacts

Primary ContactAhmed Talaat, Demonstrator

drahmed202022@gmail.com+2001013610088

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026